1. Home
  2. ULY vs GLMD Comparison

ULY vs GLMD Comparison

Compare ULY & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULY
  • GLMD
  • Stock Information
  • Founded
  • ULY 2013
  • GLMD 2000
  • Country
  • ULY United States
  • GLMD Israel
  • Employees
  • ULY N/A
  • GLMD N/A
  • Industry
  • ULY
  • GLMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • ULY
  • GLMD Health Care
  • Exchange
  • ULY Nasdaq
  • GLMD Nasdaq
  • Market Cap
  • ULY 6.3M
  • GLMD 7.5M
  • IPO Year
  • ULY N/A
  • GLMD 2014
  • Fundamental
  • Price
  • ULY $3.76
  • GLMD $1.46
  • Analyst Decision
  • ULY Strong Buy
  • GLMD Hold
  • Analyst Count
  • ULY 2
  • GLMD 1
  • Target Price
  • ULY $11.50
  • GLMD N/A
  • AVG Volume (30 Days)
  • ULY 74.4K
  • GLMD 220.7K
  • Earning Date
  • ULY 08-12-2025
  • GLMD 08-28-2025
  • Dividend Yield
  • ULY N/A
  • GLMD N/A
  • EPS Growth
  • ULY N/A
  • GLMD N/A
  • EPS
  • ULY N/A
  • GLMD N/A
  • Revenue
  • ULY $131,235,000.00
  • GLMD N/A
  • Revenue This Year
  • ULY N/A
  • GLMD N/A
  • Revenue Next Year
  • ULY $20.23
  • GLMD N/A
  • P/E Ratio
  • ULY N/A
  • GLMD N/A
  • Revenue Growth
  • ULY N/A
  • GLMD N/A
  • 52 Week Low
  • ULY $2.99
  • GLMD $1.15
  • 52 Week High
  • ULY $17.99
  • GLMD $23.80
  • Technical
  • Relative Strength Index (RSI)
  • ULY 31.35
  • GLMD 49.93
  • Support Level
  • ULY $3.75
  • GLMD $1.33
  • Resistance Level
  • ULY $4.70
  • GLMD $1.63
  • Average True Range (ATR)
  • ULY 0.37
  • GLMD 0.11
  • MACD
  • ULY -0.02
  • GLMD 0.02
  • Stochastic Oscillator
  • ULY 5.06
  • GLMD 55.13

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

Share on Social Networks: